Literature DB >> 7609162

Renal histological changes secondary to ureteropelvic junction obstruction.

J S Elder1, R Stansbrey, B B Dahms, A A Selzman.   

Abstract

The treatment of children with apparent ureteropelvic junction obstruction is controversial. In an asymptomatic infant or child the decision to recommend pyeloplasty usually is based on interpretation of the renal scan. We retrospectively analyzed the renal biopsy obtained during pyeloplasty in 55 children. Histological changes were compared to the differential renal function revealed on the preoperative renal scan. Histological changes were graded on a scale of I to V; I--normal, II--mild dilatation of the collecting tubules or Bowman's space and III to V--progressively severe changes of obstructive uropathy, including reduced glomerular number, glomerular hyalinization, cortical cysts and interstitial inflammation. Patient age ranged from 4 days to 19 years (mean 4.8 years). Mean differential function according to histological grade was I--49%, II--43%, III--42%, IV--30% and V--25%. Of 33 patients with a differential function of 40% or greater 26 (79%) had a grade I or II biopsy, while 21% had a more significant alteration in renal histology. In contrast when the differential function was less than 40% 6 of 18 patients (33%) had grade I or II disease on biopsy. In conclusion, in approximately 25% of children with ureteropelvic junction obstruction there is a disparity between preoperative differential renal function computed during diuretic renography and renal biopsy.

Entities:  

Mesh:

Year:  1995        PMID: 7609162     DOI: 10.1097/00005392-199508000-00102

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  15 in total

Review 1.  Antenatal hydronephrosis.

Authors:  David M Kitchens; C D Anthony Herndon
Journal:  Curr Urol Rep       Date:  2009-03       Impact factor: 3.092

Review 2.  MR urography: anatomy and physiology.

Authors:  J Damien Grattan-Smith
Journal:  Pediatr Radiol       Date:  2008-05

3.  Ureteropelvic junction obstruction in children: 10 years' experience in one institution.

Authors:  Jin-Cherng Sheu; Chee-Chee Koh; Pei-Yei Chang; Nien-Lu Wang; Jeng-Daw Tsai; Tsuen-Chiuan Tsai
Journal:  Pediatr Surg Int       Date:  2006-05-16       Impact factor: 1.827

Review 4.  Congenital ureteropelvic junction obstruction: human disease and animal models.

Authors:  Julie Klein; Julien Gonzalez; Mathieu Miravete; Cécile Caubet; Rana Chaaya; Stéphane Decramer; Flavio Bandin; Jean-Loup Bascands; Bénédicte Buffin-Meyer; Joost P Schanstra
Journal:  Int J Exp Pathol       Date:  2010-07-30       Impact factor: 1.925

5.  Long-term follow-up of renal function in patients after surgery for obstructive uropathy.

Authors:  Daniela Miklovicova; Olga Cervenova; Andrea Cernianska; Zuzana Jancovicova; Ladislav Dedik; Alena Vasilenkova
Journal:  Pediatr Nephrol       Date:  2008-06       Impact factor: 3.714

Review 6.  Chronic partial ureteral obstruction and the developing kidney.

Authors:  Robert L Chevalier
Journal:  Pediatr Radiol       Date:  2007-12-11

7.  Evaluation of UPJ obstruction before and after pyeloplasty using MR urography.

Authors:  Stephen B Little; Richard A Jones; J Damien Grattan-Smith
Journal:  Pediatr Radiol       Date:  2007-12-11

8.  MR urography evaluation of obstructive uropathy.

Authors:  J Damien Grattan-Smith; Stephen B Little; Richard A Jones
Journal:  Pediatr Radiol       Date:  2007-12-11

Review 9.  Mechanisms of renal injury and progression of renal disease in congenital obstructive nephropathy.

Authors:  Robert L Chevalier; Barbara A Thornhill; Michael S Forbes; Susan C Kiley
Journal:  Pediatr Nephrol       Date:  2009-10-21       Impact factor: 3.714

10.  Renal pyramid echogenicity in ureteropelvic junction obstruction: correlation between altered echogenicity and differential renal function.

Authors:  Govind Chavhan; Alan Daneman; Rahim Moineddin; Ruth Lim; Valerie Langlois; Jeffrey Traubici
Journal:  Pediatr Radiol       Date:  2008-07-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.